Regeneron forms consortium to fund exome sequencing
12-01-2018
UK government announces life sciences deal; GSK and AstraZeneca invest
11-12-2017
Marcos Silva / Shutterstock.com
The world's ”largest genetics project” to tackle deadly diseases was launched yesterday, September 11, supported by funding from the UK government, charities and four pharmaceutical companies.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
genetics, UK Biobank, sequencing, human genetics, UK government, Boris Johnson, Amgen, AstraZeneca, GlaxoSmithKline, Johnson & Johnson
